Literature DB >> 2440291

Study of movement disorders and brain iron by MR.

J N Rutledge, S K Hilal, A J Silver, R Defendini, S Fahn.   

Abstract

Heavily T2-weighted high-field MR images provide a unique opportunity for the evaluation of the extrapyramidal motor system. The images are affected by the presence of small amounts of naturally occurring paramagnetic substances--principally iron--that delineate the neostriatum (caudate and putamen), globus pallidus, red nucleus, substantia nigra, and dentate nucleus, primarily by a decrease in signal secondary to the T2* effect. Movement disorders are associated with either increased or decreased signal or both in these structures, depending on the pathologic process. In the initial evaluation of 113 patients with a variety of movement disorders, good correlation of imaging abnormalities can be made with a simplified schema of the extrapyramidal pathways and a system of classification of abnormal movements, parkinsonism/tremor, dystonia, chorea, myoclonus, and hemiballismus. Parkinsonisms are characterized by abnormalities of the cortico-ponto-cerebello-dentato-rubro-thalamo-cortico-spinal tract or the nigrostriatal tract. Dystonias are characterized by abnormalities of the neostriatum predominantly affecting the putamen. Choreas are also characterized by abnormalities of the neostriatum but predominantly affecting the caudate nucleus. Hemiballismus is characterized by lesions affecting the subthalamic nucleus or associated pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440291     DOI: 10.2214/ajr.149.2.365

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus.

Authors:  Ruth L O'Gorman; Karin Shmueli; Keyoumars Ashkan; Michael Samuel; David J Lythgoe; Asal Shahidiani; Stephen J Wastling; Michelle Footman; Richard P Selway; Jozef Jarosz
Journal:  Eur Radiol       Date:  2010-07-21       Impact factor: 5.315

Review 2.  MR imaging of midbrain pathologies.

Authors:  E Hattingen; S Blasel; M Nichtweiss; F E Zanella; S Weidauer
Journal:  Clin Neuroradiol       Date:  2010-06-09       Impact factor: 3.649

3.  Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system.

Authors:  M Eapen; D H Zald; J C Gatenby; Z Ding; J C Gore
Journal:  AJNR Am J Neuroradiol       Date:  2010-12-23       Impact factor: 3.825

4.  'Face of the giant panda' sign in Wilson disease.

Authors:  Rajoo Thapa; Apurba Ghosh
Journal:  Pediatr Radiol       Date:  2008-10-07

Review 5.  Contributions to magnetic susceptibility of brain tissue.

Authors:  Jeff H Duyn; John Schenck
Journal:  NMR Biomed       Date:  2016-05-30       Impact factor: 4.044

6.  Genetics of Parkinson disease.

Authors:  E Ben-David; R Tu
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-04       Impact factor: 3.825

7.  Type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl.

Authors:  R Tanaka; T Momoi; A Yoshida; M Okumura; S Yamakura; Y Takasaki; T Kiyomasu; C Yamanaka
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

8.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

9.  Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.

Authors:  Parastou Foroutan; Melissa E Murray; Shinsuke Fujioka; Katherine J Schweitzer; Dennis W Dickson; Zbigniew K Wszolek; Samuel C Grant
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

10.  Improved subthalamic nucleus depiction with quantitative susceptibility mapping.

Authors:  Tian Liu; Sarah Eskreis-Winkler; Andrew D Schweitzer; Weiwei Chen; Michael G Kaplitt; A John Tsiouris; Yi Wang
Journal:  Radiology       Date:  2013-05-14       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.